Protalix completes private placement of convertible notes

Protalix BioTherapeutics Inc. (NYSE-M:PLX; Tel Aviv:PLX), Carmiel, Israel Business: Endocrine/Metabolic, Biosimilars, Biomanufacturing Date completed: 9/12/13 Type: Private placement of convertible no...